Results 121 to 130 of about 2,311,361 (335)

Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children

JAMA Network Open, 2021
Key Points Question Among children with a COVID-19 diagnosis, what conditions are common, and which are associated with severe COVID-19 illness? Findings In this cross-sectional study of 43 465 patients aged 18 years or younger with COVID-19, more than ...
Lyudmyla Kompaniyets, N. Agathis, J. Nelson, L. E. Preston, Jean Y. Ko, Brook Belay, A. Pennington, M. Danielson, C. L. DeSisto, J. Chevinsky, Lyna Schieber, H. Yusuf, J. Baggs, W. M. Mac Kenzie, Karen K. Wong, T. Boehmer, A. Gundlapalli, Alyson B. Goodman   +17 more
semanticscholar   +1 more source

Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli, Mudasir Andrabi, Tova Cohen, Pranali G. Patel, Tapasya Katta, Chen Lin   +5 more
wiley   +1 more source

Mavrilimumab for severe COVID-19 [PDF]

The Lancet Rheumatology, 2020
Khan, Adil Rashid, Soneja, Manish, Tirlangi, Praveen Kumar, Wig, Naveet   +3 more
openaire   +5 more sources

Pulmonary alveolar proteinosis following severe COVID - 19 infection: A case report

Respiratory Medicine Case Reports
A 67-year-old male, with a history of severe COVID-19 infection and exposure to talc was seen for worsening shortness of breath for months, requiring supplemental oxygen.
Samina Martin, Shivu Kaushik, Bharat Bajantri   +2 more
doaj   +1 more source

Glycated hemoglobin level on admission associated with progression to severe disease in hospitalized patients with non‐severe coronavirus disease 2019

Journal of Diabetes Investigation, 2022
Aims/Introduction Poor glycemic control is known to be associated with severe infection development. This retrospective observational study examined whether glycemic control before coronavirus disease 2019 (COVID‐19) onset contributes to progression from
Ryutaro Numaguchi, Masafumi Kurajoh, Yoshikazu Hiura, Takumi Imai, Tomoaki Morioka, Mika Saito, Satoshi Shiraishi, Masanori Emoto, Yukio Nishiguchi   +8 more
doaj   +1 more source

Severe COVID-19 during Pregnancy and Possible Vertical Transmission

American Journal of Perinatology, 2020
There are few cases of pregnant women with novel corona virus 2019 (COVID-19) in the literature, most of them with a mild illness course. There is limited evidence about in utero infection and early positive neonatal testing.
M. Alzamora, Tania Paredes, David Cáceres, Camille M Webb, L. Valdez, M. La Rosa   +5 more
semanticscholar   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Annals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree   +12 more
wiley   +1 more source

Dysbiosis of gut microbiota in patients with severe COVID‐19

Acute Medicine & Surgery
Aim Altered gut microbiota has been proposed as one of the causes of exacerbation of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2/COVID‐19) from the perspective of the gut–lung axis.
Kentaro Shimizu, Haruhiko Hirata, Natsuko Tokuhira, Daisuke Motooka, Shota Nakamura, Akiko Ueda, Jotaro Tachino, Moe Koide, Akinori Uchiyama, Hiroshi Ogura, Jun Oda   +10 more
doaj   +1 more source

Clinical impacts of COVID-19 on severe exacerbation and mortality in interstitial lung disease: prognosis 30 days after infection [PDF]

The Korean Journal of Internal Medicine
Background/Aims The impact of coronavirus disease 2019 (COVID-19) on severe exacerbation and mortality in interstitial lung disease (ILD) is unclear.
Bo-Guen Kim, Sun-Kyung Lee, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Sang-Heon Kim, Ho Joo Yoon, Hyun Lee   +8 more
doaj   +1 more source

The effect of vascular risk factor burden on the severity of COVID-19 illness, a retrospective cohort study

Respiratory Research, 2020
Background Patients with cardiovascular comorbidities are at high risk of poor outcome from COVID-19. However, how the burden (number) of vascular risk factors influences the risk of severe COVID-19 disease remains unresolved.
Houwei Du, Xiaobin Pan, Nan Liu, Junnian Chen, Xiaoling Chen, David J. Werring, Gareth Ambler, Xiaoqing Li, Ronghua Chen, Yixian Zhang, Huayao Huang, Feifei Lin, Pincang Xia, Chao Chen, Zhenyang Zheng, Sangru Wu, Hanhan Lei, Lei Gao, Mingxu Huang, Kexu Lin, Xiaoping Xu, Yukun Luo, Ziwen Zhao, Chen Li, Hailong Lin, Yu Lin, Zhenghui Huang, Rongxiang Cao, Limin Chen, On behalf of the Fujian Medical Team Support Wuhan for COVID-19   +29 more
doaj   +1 more source